Quadrature Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Quadrature Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-32,725	Closed	-$288K	–	764
2019 Q4	$288K	Buy	+32,725	New	+$245K	0.01%	405

Other funds holding NPTN

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quadrature Capital's NPTN Position: Q1 2020 in Review

Quadrature Capital sold out of NEOPHOTONICS CORP (NPTN) in Q1 2020, closing a stake of 32,725 shares — an estimated $288K sold.

Quadrature Capital first reported a position in NPTN in Q4 2019 and held it in 1 quarter. The position peaked at $288K in Q4 2019. 135 funds tracked by Wall St. Rank hold NPTN as of Q1 2020.

Quadrature Capital reported no remaining NEOPHOTONICS CORP position as of Q1 2020 after selling out during the quarter.
Quadrature Capital sold 32,725 NEOPHOTONICS CORP shares in Q1 2020, an estimated $288K.
Quadrature Capital first reported a position in NEOPHOTONICS CORP in Q4 2019 and held it in 1 quarter.
Quadrature Capital's NEOPHOTONICS CORP position peaked at $288K in Q4 2019.
135 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2020.

Based on Quadrature Capital's 13F filing for Q1 2020, filed 15 May 2020.